Metraipolis › archive › dc_42273fec5ff4

Immunological Crossroads: Optimizing Antirejection Regimens to Sustain Antitumor Immunity in Liver Transplant Recipients with Hepatocellular Carcinoma — Europe PMC PMID:41375072

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41375072
DOI
10.3390/cancers17233871
License (as archived)
solo-consultazione
Archived
2026-11-08T00:45:42.626Z
SHA-256 of the archived text
2a8a4551b498b6d862a3071c7480b3704f6429ee64ea63039bd9316c4a5538ac
Stable URL of this page
https://metraipolis.com/documento/dc_42273fec5ff4

How to cite

Immunological Crossroads: Optimizing Antirejection Regimens to Sustain Antitumor Immunity in Liver Transplant Recipients with Hepatocellular Carcinoma — Europe PMC PMID:41375072 — Europe PMC (en), https://europepmc.org/article/MED/41375072 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42273fec5ff4 (Metraipolis archive dc_42273fec5ff4, sha256 2a8a4551b498b6d862a3071c7480b3704f6429ee64ea63039bd9316c4a5538ac)
BibTeX
@misc{dc42273fec5ff4,
  title = {Immunological Crossroads: Optimizing Antirejection Regimens to Sustain Antitumor Immunity in Liver Transplant Recipients with Hepatocellular Carcinoma — Europe PMC PMID:41375072},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375072},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42273fec5ff4; sha256 2a8a4551b498b6d862a3071c7480b3704f6429ee64ea63039bd9316c4a5538ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375072. Agents can read the archived copy with the MCP tool read_document.